Unknown

Dataset Information

0

Activation of PKA leads to mesenchymal-to-epithelial transition and loss of tumor-initiating ability.


ABSTRACT: The epithelial-to-mesenchymal transition enables carcinoma cells to acquire malignancy-associated traits and the properties of tumor-initiating cells (TICs). TICs have emerged in recent years as important targets for cancer therapy, owing to their ability to drive clinical relapse and enable metastasis. Here, we propose a strategy to eliminate mesenchymal TICs by inducing their conversion to more epithelial counterparts that have lost tumor-initiating ability. We report that increases in intracellular levels of the second messenger, adenosine 3',5'-monophosphate, and the subsequent activation of protein kinase A (PKA) induce a mesenchymal-to-epithelial transition (MET) in mesenchymal human mammary epithelial cells. PKA activation triggers epigenetic reprogramming of TICs by the histone demethylase PHF2, which promotes their differentiation and loss of tumor-initiating ability. This study provides proof-of-principle for inducing an MET as differentiation therapy for TICs and uncovers a role for PKA in enforcing and maintaining the epithelial state.

SUBMITTER: Pattabiraman DR 

PROVIDER: S-EPMC5131720 | biostudies-literature | 2016 Mar

REPOSITORIES: biostudies-literature

altmetric image

Publications

Activation of PKA leads to mesenchymal-to-epithelial transition and loss of tumor-initiating ability.

Pattabiraman Diwakar R DR   Bierie Brian B   Kober Katharina Isabelle KI   Thiru Prathapan P   Krall Jordan A JA   Zill Christina C   Reinhardt Ferenc F   Tam Wai Leong WL   Weinberg Robert A RA  

Science (New York, N.Y.) 20160301 6277


The epithelial-to-mesenchymal transition enables carcinoma cells to acquire malignancy-associated traits and the properties of tumor-initiating cells (TICs). TICs have emerged in recent years as important targets for cancer therapy, owing to their ability to drive clinical relapse and enable metastasis. Here, we propose a strategy to eliminate mesenchymal TICs by inducing their conversion to more epithelial counterparts that have lost tumor-initiating ability. We report that increases in intrace  ...[more]

Similar Datasets

| S-EPMC3366719 | biostudies-literature
| S-EPMC3189192 | biostudies-literature
| S-EPMC3123810 | biostudies-other
| S-EPMC3477166 | biostudies-literature
| S-EPMC3225383 | biostudies-literature
| S-EPMC5242415 | biostudies-other
| S-EPMC5029733 | biostudies-literature
| S-EPMC4965557 | biostudies-literature
| S-EPMC3903644 | biostudies-literature
2012-07-23 | E-GEOD-24868 | biostudies-arrayexpress